Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

4.68
Delayed Data
As of 10:38am ET
 +0.10 / +2.18%
Today’s Change
2.78
Today|||52-Week Range
7.72
+33.33%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close4.58
Today’s open4.62
Day’s range4.62 - 4.96
Volume12,123
Average volume (3 months)37,256
Market cap$55.6M
Dividend yield--
Data as of 10:38am ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-55.21%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales85.49
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...+0.09+3.37%
ZSANZosano Pharma Corp-0.04-2.35%
NBYNovaBay Pharmaceutic...+0.20+5.33%
NTECIntec Pharma Ltd-0.10-1.98%
Data as of 11:44am ET, 03/28/2017

Financials

Last reporting dateMarch 23, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$467.0K
Annual profit (last year)-$17.0M
Net profit margin-3,630.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Yohai Stenzler
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs